top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Autore Ecke Thorsten
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (240 p.)
Soggetto topico Medicine
Soggetto non controllato Metallothionein
urothelium
urothelial cancer
cadmium exposure
zinc transporter
bladder
TAGLN
F-actin
PTEN
p53
tumorigenesis
proliferation
invasion
TERT promoter mutations
FGFR3
non muscle invasive bladder cancer
BCG therapy
bladder cancer
JAK-STAT pathway
combination therapy
oncolytic adenovirus
virotherapy
STAT3/5 inhibitor
JAK inhibitor
XVir-N-31
bladder cancer detection
urinary biomarkers
DNA methylation
ECRG4
ITIH5
biomarker
cancer
grade
metabolomics
MS
NMR
biomarkers
tumor markers
prognosis
heparanase
syndecan-1
heparan sulfate proteoglycans (HSPGs)
urothelial carcinoma
miRNA
quantitative PCR
tumor marker
voided urine cytology
KDM7A
histone demethylase
TC-E 5002
androgen receptor
drug resistance
non-invasive detection
telomerase
somatic mutations
TERT promoter region
muscle-invasive bladder cancer
chemotherapy
immunotherapy
personalized medicine
predictive biomarker
survivin
BIRC5
macrophage
KRT20
ERBB2
MIBC
prediction
RT-qPCR
adjuvant chemotherapy
survival
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557142003321
Ecke Thorsten  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrating Clinical and Translational Research Networks-Building Team Medicine
Integrating Clinical and Translational Research Networks-Building Team Medicine
Autore Salgia Ravi
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (250 p.)
Soggetto topico Medicine
Soggetto non controllato renal cell carcinoma
team medicine
translational research
community practice
clinical trials
geriatric oncology
older adults
cancer clinical trials
recruitment
community
team science
bladder cancer
urothelial carcinoma
COVID-19
team-based medicine
colorectal cancer
precisian medicine
academic and community oncology
cancer center
lung cancer
lung cancer screening
low-dose CT scans
cancer prevention
smoking cessation
tobacco control
national guidelines for screening and prevention
pharmaceutical aids to smoking cessation
non-small cell lung cancer
driver mutations
testing rates
receptor tyrosine kinases
actionable mutations
next-generation sequencing
fast-and-frugal trees
personalized medicine
minorities
ethnicity
race
breast cancer
research
HER2-directed therapy
community oncology
academic cancer center
precision medicine
cancer genetics
cancer genomics
small cell lung cancer
immunotherapy
epithelial ovarian cancer
frontline treatment
surgical debulking
adjuvant chemotherapy
maintenance therapy
PARP inhibitor
genetics counseling
clinical research
oropharyngeal cancer
concurrent chemoradiation therapy
human papillomavirus
feeding tube dependency
value-based care
value-based cancer care
oncology pathways
Early Recovery After Surgery (ERAS)
team-based care
oncology medical home
integrated cancer care
supportive care pathways
surgical pathways
cancer care plans
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557124403321
Salgia Ravi  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Autore Uchino Junji
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (258 p.)
Soggetto topico Medicine
Soggetto non controllato non-small cell lung cancer
previously treated patients
phase I/II trial
chemotherapy
docetaxel
S-1
immunotherapy
rechallenge
retrospective analysis
pulmonary pleomorphic carcinoma
prognostic factor
glucose transporter 1
lung cancer
multiple cancers
metastasis
sequencing
mutation
genomic diagnosis
FDG-PET
immune checkpoint inhibitor
PD-1
prognosis
RAD51B methylation
PD-L1 expression
predictive biomarker
PD-1 blockade
interstitial lung disease
pulmonary fibrosis
radiology and other imaging
non-small-cell lung cancer
epidermal growth factor receptor
tyrosine kinase inhibitors
TP53 mutations
responsiveness
targeted therapy
network meta-analysis
stage IIIA-N2
surgery
immune checkpoint inhibitors
biomarker
nonsmall cell lung cancer
HIP1R
PD-L1
RUNX1
methylation
survival
EGFR-TKI
T790M
osimertinib
immune-related adverse events
endocrine disorders
tumor-bearing patients
PD-1 inhibitors
PD-L1 inhibitors
meta-analysis
nivolumab
Expanded Access Program
real-world data
daily practice
prognostic factors
NSCLC
KRAS
DNA polymerase beta
platinum-based first-line
adjuvant chemotherapy
β-catenin
lung neoplasms
nucleotide-diphosphate kinase
recurrence
unresectable
salvage surgery
oligometastasis
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Non-small Cell Lung Cancer
Record Nr. UNINA-9910557489703321
Uchino Junji  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Precision Medicine in Solid Tumors
Precision Medicine in Solid Tumors
Autore Dey Nandini
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (304 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato pediatric tumors
tumor mutational burden
TMB
whole-exome sequencing
gene panel sequencing
immune checkpoint inhibitors
glioblastoma prognosis
overall survival
extent of resection
random forest
Decision tree
personalized precision oncology
circulating free DNA
liquid biopsy
epidermal growth factor receptor
tyrosine kinase inhibitor
osimertinib
comprehensive genomic profiling
molecular genotyping
intratumor heterogeneity
multiple biopsies
tumor evolution
clonality classification
strategic therapeutic intervention
thymoma
driver mutation
sequencing
molecular barcoding
EGFR mutation
EGFR-TKI
cfDNA
NGS
digital enrichment
next-generation sequencing
solid cancer
universal health-care system
precision medicine
presumed germline findings
clinical guideline
non-small cell lung cancer
outcome
adjuvant chemotherapy
anaplastic lymphoma receptor tyrosine kinase
HNSCC
ctDNA
tDNA
DDR genes
PARP inhibitors
new drug development
next-generation sequencing (NGS)
open data
regulatory reform
tumor profiling test
triple-negative breast cancer (TNBC)
breast cancer
targeted therapy
TNBC subtypes
immunotherapy
cancer
screening
smoking
electronic records
PD-L1
cancer-associated fibroblasts
resistance
chemotherapy
CTC
immunocytochemistry
parallel double-detection
laboratory-friendly
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910595078103321
Dey Nandini  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Autore Satoi Sohei
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (214 p.)
Soggetto topico Medicine
Surgery
Soggetto non controllato unresectable pancreatic ductal adenocarcinoma
conversion surgery
early recurrence
pancreatic neoplasm/analysis
pancreatic neoplasm/surgery
tumor location
survival
clinical staging
branch duct intraductal papillary mucinous neoplasm
risk factor
malignancy
meta-analysis
laparoscopic
pancreaticoduodenectomy
pancreatic cancer
borderline resectable
neoadjuvant treatment
chemoradiotherapy
prognostic nutritional index
isolated local recurrence
pancreatectomy
pancreatic remnant
recurrence
redo surgery
pancreatic exocrine insufficiency
adjuvant chemotherapy
biliary drainage
prehabilitation
ERAS
arterial resection
total pancreatectomy
neoadjuvant therapy
pancreatic ductal adenocarcinoma
surgical treatment
technical advances
pancreatic main duct dilatation
intraductal papillary mucinous neoplasm
high grade dysplasia
invasive carcinoma
pancreatic cystic neoplasm
cell-free DNA
mesopancreas
superior mesenteric artery
nerve and fibrous tissues
lymph node dissection
R0 resection
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557364803321
Satoi Sohei  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui